טוען...

Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure

BACKGROUND: Galectin-3 plasma levels (gal-3) were shown to correlate with the scar burden in chronic heart failure (CHF) setting. As scar burden predicts response to stem cell therapy, we sought to explore a correlation between gal-3 and response to CD34+ cell transplantation in patients with CHF. M...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Dis Markers
Main Authors: Poglajen, Gregor, Ksela, Jus, Frljak, Sabina, Zemljic, Gregor, Boznar Alic, Elizabeta, Cerar, Andraz, Vrtovec, Bojan
פורמט: Artigo
שפה:Inglês
יצא לאור: Hindawi 2019
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6925830/
https://ncbi.nlm.nih.gov/pubmed/31885743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8636930
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!